[1]. 李林,柳硕岩,朱坤寿,等.早期食管癌淋巴转移规律与预后分析[J].中华肿瘤杂志,2009,31(3):226-229. [2]. 祝淑钗,宋长亮,沈文斌,等.食管癌根治性切除术后患者预后的影响因素分析[J].中华肿瘤杂志,2012,34(4):281-286. [3]. 李春海,李克勤.肿瘤微血管生成的机制与肿瘤侵袭和转移[J].中华肿瘤杂志,2002,22(3):181-183. [4]. 刘志才,管福顺,郭建庄,等. 食管贲门癌脉管瘤栓与病理相关因素分析[J].癌症,2002,21(5):530-532. [5]. Del CJ, Corte MD, Alvarez A, et al. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance[J]. J Cancer Res Clin Oncol. 2008, 134(2):153-161. [6]. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma[J]. Surgery. 2000, 127(6):603-608. [7]. 吴孟超,吴在德. 黄家驷外科学[M].第七版.北京:人民卫生出版社,2008:2100. [8]. Wang YD,Wu P,Mao JD,et al. Relationship between vascular invasion and microvessel density and micrometastasis[J]. World J Gastroenterol,2007,13(46):6269-6273. [9]. Mori D, Yamasaki F, Shibaki M, et al. Lateral peritumoral lymphatic vessel invasion can predict lymph node metastasis in esophageal squamous cell carcinoma[J]. Mod Pathol. 2007, 20(6):694-700. [10]. Roma AA, Magi-Galluzzi C, Kral MA, et al. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma[J]. Mod Pathol. 2006, 19(3):392-398. [11]. Wong SY, Haack H, Crowley D, et al. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis[J]. Cancer Res. 2005, 65(21):9789-9798. [12]. Agarwal B, Saxena R, Morimiya A, et al. Lymphangiogenesis does not occur in breast cancer[J]. Am J Surg Pathol. 2005, 29(11):1449-1455. [13]. 李斌,相加庆,张亚伟,等. 食管癌淋巴结转移特点及其危险因素[J]. 中华胃肠外科杂志,2011(14):711-714. [14]. Sgourakis G,Gockel I,Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms:a systematic review[J]. World J Gastroenterol,2013,19 (9):1424-1437. [15]. 霍小东,王洪江,庞作良,等. 339例中晚期胸段食管鳞癌术后生存评价及预后因素分析[J]. 实用肿瘤杂志,2010,25 (3):273-277.